Vilija Oke

1.1k total citations
24 papers, 741 citations indexed

About

Vilija Oke is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Vilija Oke has authored 24 papers receiving a total of 741 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Rheumatology, 15 papers in Immunology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Vilija Oke's work include Systemic Lupus Erythematosus Research (15 papers), T-cell and B-cell Immunology (10 papers) and Atherosclerosis and Cardiovascular Diseases (4 papers). Vilija Oke is often cited by papers focused on Systemic Lupus Erythematosus Research (15 papers), T-cell and B-cell Immunology (10 papers) and Atherosclerosis and Cardiovascular Diseases (4 papers). Vilija Oke collaborates with scholars based in Sweden, United States and India. Vilija Oke's co-authors include Marie Wahren‐Herlenius, Elisabet Svenungsson, Iva Gunnarsson, Agneta Zickert, Susanna Eketjäll, Helena Idborg, Timothy B. Niewold, Jessica M. Dorschner, Johanna Gustafsson and Filippa Nyberg and has published in prestigious journals such as International Journal of Molecular Sciences, Frontiers in Immunology and Annals of the Rheumatic Diseases.

In The Last Decade

Vilija Oke

22 papers receiving 732 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vilija Oke Sweden 14 475 471 126 109 98 24 741
William A. Figgett Australia 11 442 0.9× 182 0.4× 135 1.1× 100 0.9× 82 0.8× 18 768
Andrea L. Sestak United States 12 557 1.2× 631 1.3× 113 0.9× 166 1.5× 141 1.4× 17 946
Nina Daha Netherlands 13 249 0.5× 381 0.8× 141 1.1× 113 1.0× 90 0.9× 22 699
K L Moser United States 12 426 0.9× 371 0.8× 159 1.3× 124 1.1× 60 0.6× 19 699
Christopher L. Pinder United Kingdom 6 422 0.9× 345 0.7× 188 1.5× 68 0.6× 92 0.9× 9 743
Anette Peddinghaus Germany 5 443 0.9× 167 0.4× 89 0.7× 100 0.9× 74 0.8× 8 611
Susanna Brauner Sweden 14 505 1.1× 269 0.6× 253 2.0× 69 0.6× 102 1.0× 24 924
Sang Taek Kim United States 4 414 0.9× 280 0.6× 91 0.7× 64 0.6× 178 1.8× 7 653
Philip Tombleson United Kingdom 3 360 0.8× 336 0.7× 154 1.2× 57 0.5× 76 0.8× 3 639
A.H.L. Fielder United Kingdom 15 601 1.3× 393 0.8× 124 1.0× 184 1.7× 46 0.5× 23 893

Countries citing papers authored by Vilija Oke

Since Specialization
Citations

This map shows the geographic impact of Vilija Oke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vilija Oke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vilija Oke more than expected).

Fields of papers citing papers by Vilija Oke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vilija Oke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vilija Oke. The network helps show where Vilija Oke may publish in the future.

Co-authorship network of co-authors of Vilija Oke

This figure shows the co-authorship network connecting the top 25 collaborators of Vilija Oke. A scholar is included among the top collaborators of Vilija Oke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vilija Oke. Vilija Oke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Niewold, Timothy B., Julia S. Lehman, Iva Gunnarsson, Alexander Meves, & Vilija Oke. (2025). Role of interleukin-16 in human diseases: a novel potential therapeutic target. Frontiers in Immunology. 16. 1524026–1524026.
2.
Tacconelli, Stefania, Iva Gunnarsson, Vilija Oke, et al.. (2025). Janus kinase inhibitors enhance prostanoid biosynthesis in human whole blood in vitro: implications for cardiovascular side effects and prevention strategies. Annals of the Rheumatic Diseases. 84(9). 1549–1560. 2 indexed citations
3.
Oke, Vilija, Anders Larsson, Jan Nilsson, et al.. (2024). Anti-histone and anti-nucleosome rather than anti-dsDNA antibodies associate with IFN-induced biomarkers in Sudanese and Swedish SLE patients. Lara D. Veeken. 64(3). 1170–1178. 3 indexed citations
4.
Faustini, Francesca, Agneta Zickert, Anders Larsson, et al.. (2022). Interleukin (IL) 16: a candidate urinary biomarker for proliferative lupus nephritis. Lupus Science & Medicine. 9(1). e000744–e000744. 14 indexed citations
5.
Díaz-Gallo, Lina-Marcela, Vilija Oke, Emeli Lundström, et al.. (2021). Four Systemic Lupus Erythematosus Subgroups, Defined by Autoantibodies Status, Differ Regarding HLA‐DRB1 Genotype Associations and Immunological and Clinical Manifestations. ACR Open Rheumatology. 4(1). 27–39. 28 indexed citations
6.
Niewold, Timothy B., Alexander Meves, Julia S. Lehman, et al.. (2021). Proteome study of cutaneous lupus erythematosus (CLE) and dermatomyositis skin lesions reveals IL-16 is differentially upregulated in CLE. Arthritis Research & Therapy. 23(1). 132–132. 13 indexed citations
7.
Idborg, Helena & Vilija Oke. (2021). Cytokines as Biomarkers in Systemic Lupus Erythematosus: Value for Diagnosis and Drug Therapy. International Journal of Molecular Sciences. 22(21). 11327–11327. 35 indexed citations
8.
Björk, Albin, Johannes Mofors, Marika Kvarnström, et al.. (2020). Interferon activation status underlies higher antibody response to viral antigens in patients with systemic lupus erythematosus receiving no or light treatment. Lara D. Veeken. 60(3). 1445–1455. 3 indexed citations
9.
Kvarnström, Marika, Agneta Zickert, Vilija Oke, et al.. (2019). Sjögren Syndrome in Systemic Lupus Erythematosus: A Subset Characterized by a Systemic Inflammatory State. The Journal of Rheumatology. 47(6). 865–875. 28 indexed citations
10.
Oke, Vilija, Iva Gunnarsson, Jessica M. Dorschner, et al.. (2019). High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus. Arthritis Research & Therapy. 21(1). 107–107. 147 indexed citations
11.
Oke, Vilija, Susanna Brauner, Anders Larsson, et al.. (2017). IFN-λ1 with Th17 axis cytokines and IFN-α define different subsets in systemic lupus erythematosus (SLE). Arthritis Research & Therapy. 19(1). 139–139. 49 indexed citations
12.
Eketjäll, Susanna, Helena Idborg, Johanna Gustafsson, et al.. (2016). FRI0014 Multiplex Screening of Cytokines in The Search for Disease Activity Markers of SLE. Annals of the Rheumatic Diseases. 75. 430–431. 1 indexed citations
13.
Oke, Vilija & Marie Wahren‐Herlenius. (2013). Cutaneous lupus erythematosus: clinical aspects and molecular pathogenesis. Journal of Internal Medicine. 273(6). 544–554. 34 indexed citations
14.
Oke, Vilija & Marie Wahren‐Herlenius. (2012). The immunobiology of Ro52 (TRIM21) in autoimmunity: A critical review. Journal of Autoimmunity. 39(1-2). 77–82. 135 indexed citations
15.
Kuhn, Annegret, Anna Woźniacka, Jacek C. Szepietowski, et al.. (2011). Photoprovocation in Cutaneous Lupus Erythematosus: A Multicenter Study Evaluating a Standardized Protocol. Journal of Investigative Dermatology. 131(8). 1622–1630. 38 indexed citations
16.
Oke, Vilija, Ismini Vassilaki, Alexander Espinosa, et al.. (2009). High Ro52 Expression in Spontaneous and UV-Induced Cutaneous Inflammation. Journal of Investigative Dermatology. 129(8). 2000–2010. 50 indexed citations
17.
Espinosa, Alexander, Vilija Oke, Åse Elfving, et al.. (2008). The autoantigen Ro52 is an E3 ligase resident in the cytoplasm but enters the nucleus upon cellular exposure to nitric oxide. Experimental Cell Research. 314(20). 3605–3613. 20 indexed citations
18.
Thirunavukarasu, M, et al.. (1990). Comparative clinical evaluation of buspirone and diazepam in generalized anxiety disorders. Current Therapeutic Research. 47(3). 502–510. 5 indexed citations
19.
Oke, Vilija, et al.. (1989). Double‐blind clinical trial of nefopam in comparison with pentazocine in surgical patients. International Journal of Clinical Practice. 43(6). 209–214. 5 indexed citations
20.
Oke, Vilija, et al.. (1986). Efficacy and safety of an ibuprofen and dextropropoxyphene combination (Ibudex) in medical practice. International Journal of Clinical Practice. 40(11). 482–487.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William A. Figgett Breakdown of academic impact, for papers by Andrea L. Sestak Breakdown of academic impact, for papers by Nina Daha Breakdown of academic impact, for papers by K L Moser Breakdown of academic impact, for papers by Christopher L. Pinder Breakdown of academic impact, for papers by Anette Peddinghaus Breakdown of academic impact, for papers by Susanna Brauner Breakdown of academic impact, for papers by Sang Taek Kim Breakdown of academic impact, for papers by Philip Tombleson Breakdown of academic impact, for papers by A.H.L. Fielder
Rankless by CCL
2026